Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $36,535 | 1,652 | 77.0% |
| Consulting Fee | $10,200 | 6 | 21.5% |
| Travel and Lodging | $333.68 | 2 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 0.4% |
| Education | $162.99 | 11 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC | $13,631 | 135 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,047 | 182 | $0 (2024) |
| Novo Nordisk Inc | $3,663 | 212 | $0 (2024) |
| Amgen Inc. | $2,919 | 101 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,553 | 109 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,237 | 128 | $0 (2024) |
| PFIZER INC. | $2,110 | 138 | $0 (2024) |
| Lilly USA, LLC | $1,758 | 91 | $0 (2024) |
| CeQur Corporation | $1,428 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,256 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,874 | 148 | CeQur Corporation ($735.01) |
| 2023 | $4,864 | 169 | CeQur Corporation ($692.64) |
| 2022 | $4,105 | 186 | Bayer HealthCare Pharmaceuticals Inc. ($532.81) |
| 2021 | $4,204 | 202 | Novo Nordisk Inc ($550.06) |
| 2020 | $3,260 | 183 | Novo Nordisk Inc ($678.98) |
| 2019 | $5,125 | 240 | PFIZER INC. ($695.75) |
| 2018 | $16,387 | 269 | Ironwood Pharmaceuticals, Inc ($11,856) |
| 2017 | $4,613 | 275 | AstraZeneca Pharmaceuticals LP ($731.68) |
All Payment Transactions
1,672 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Obesity | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: GI | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: GI | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Obesity | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.16 | General |
| 11/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 11/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.92 | General |
| Category: Neurology | ||||||
| 10/24/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.19 | General |
| Category: GI | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,127 | 3,277 | $448,372 | $217,362 |
| 2022 | 11 | 1,018 | 2,671 | $381,079 | $191,910 |
| 2021 | 14 | 948 | 2,294 | $315,967 | $160,629 |
| 2020 | 16 | 881 | 2,341 | $250,726 | $122,457 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 201 | 1,407 | $211,030 | $90,133 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 551 | $93,670 | $50,013 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 326 | $42,380 | $21,179 | 50.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 130 | 393 | $31,460 | $19,740 | 62.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $29,690 | $16,084 | 54.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 121 | $15,125 | $7,765 | 51.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 121 | 121 | $4,840 | $2,225 | 46.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 36 | 40 | $4,400 | $2,209 | 50.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 22 | $4,268 | $2,160 | 50.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $1,714 | $1,452 | 84.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 19 | $2,850 | $1,241 | 43.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 49 | 49 | $1,715 | $1,073 | 62.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 19 | 25 | $3,000 | $1,071 | 35.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 19 | $1,710 | $864.50 | 50.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $520.00 | $152.49 | 29.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 196 | 1,163 | $174,450 | $76,957 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 517 | $87,890 | $50,548 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 478 | $62,140 | $31,878 | 51.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 122 | 122 | $29,280 | $16,243 | 55.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 81 | 85 | $9,350 | $5,894 | 63.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 143 | 143 | $5,720 | $2,673 | 46.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 15 | $3,900 | $2,511 | 64.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 55 | 59 | $2,065 | $1,858 | 90.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 54 | 58 | $2,204 | $1,736 | 78.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 16 | 19 | $2,280 | $878.35 | 38.5% |
About Dr. Ziad Berri, MD
Dr. Ziad Berri, MD is a Internal Medicine healthcare provider based in Dearborn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881786770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ziad Berri, MD has received a total of $47,432 in payments from pharmaceutical and medical device companies, with $4,874 received in 2024. These payments were reported across 1,672 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($36,535).
As a Medicare-enrolled provider, Berri has provided services to 3,974 Medicare beneficiaries, totaling 10,583 services with total Medicare billing of $692,359. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dearborn, MI
- Active Since 09/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881786770
Products in Payments
- DUZALLO (Drug) $11,835
- FARXIGA (Drug) $2,044
- JARDIANCE (Drug) $1,966
- Linzess (Drug) $1,549
- CeQur Simplicity (Device) $1,428
- Ozempic (Drug) $1,258
- Kerendia (Drug) $1,256
- TRELEGY ELLIPTA (Drug) $1,152
- Aimovig (Biological) $818.76
- XARELTO (Drug) $790.84
- ELIQUIS (Drug) $752.10
- Repatha (Biological) $672.10
- CHANTIX (Drug) $649.38
- Otezla (Drug) $605.37
- ENTRESTO (Drug) $589.75
- INJECTAFER (Drug) $582.08
- Saxenda (Drug) $553.13
- BREZTRI (Drug) $537.89
- REXULTI (Drug) $527.02
- JANUVIA (Drug) $517.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dearborn
Wassim Younes, Md, Rph, MD, RPH
Internal Medicine — Payments: $215,063
Abdulhassan Saad, M.d, M.D
Internal Medicine — Payments: $199,745
Dr. Opada Alzohaili, Md, MD
Internal Medicine — Payments: $39,452
Mohamad Khansa
Internal Medicine — Payments: $36,417
Dr. Mazen Elatrache, Md, MD
Internal Medicine — Payments: $28,467
Dr. Mohammed Obeid, D.o, D.O
Internal Medicine — Payments: $22,141